International Conference on Drug Design and Discovery (ICDDD2008)

Venue: Dubai World Trade Center

Location: Dubai, United Arab Emirates

Event Date/Time: Feb 03, 2008 End Date/Time: Feb 06, 2008
Early Registration Date: Nov 02, 2007
Report as Spam

Description

On behalf of the Organizing Committee, it gives us great pleasure to invite you to
participate in the 1st International Conference on Drug Design & Discovery, which will
take place in Dubai, UAE from February 3 - 6, 2008.
The conference will be hosting leading scientist including several Nobel Laureates from
academia and industry world wide. The event will provide an exclusive platform to
discuss the latest developments in various fields of drug design and discovery. The
participants will be exposed to many interesting perspectives on how the science and
technology of drug discovery is changing and will continue to change in the modern
era.
The conference will be geared to specialists in Cancer, Cardiovascular, CNS,
Pharmacogenomics, Protein & Peptide, Inflammation & Allergy, Drug Delivery, Medicinal
Chemistry and Nanotechnology.
Dubai in the spring is the charming venue of the conference. The city has a very rich
social and cultural heritage. It is endowed with unrivalled beauty complimented by
unique juxtaposition of modern and historical Arab architecture.

CHAIRMAN
Prof. Richard R. Ernst (Nobel Laureate)
ETH Zürich, Laboratorium für Physikalische Chemie
Zürich, Switzerland
ORGANIZING SECRETARIES
William A. Denny (The University of Auckland, New Zealand)
Anti-cancer Drug Design and Discovery
Allen B. Reitz (Johnson & Johnson Pharmaceutical Research and Development, PA, USA)
CNS Drug Design and Discovery
Petr Kocis (Enabling Science & Technology, AstraZeneca R & D Boston, MA, USA)
Enabling Technology Drug Design and Discovery
Robert J. Gould (Merck Research Laboratories, PA, USA)
Cardiovascular Drug Design and Discovery
P. Talaga (Discovery Technologies, Global Chemistry, Belgium)
Frontiers in Medicinal Chemistry
Kenji Izuhara (Saga Medical School, Japan)
Inflammation and Allergy Drug Design and Discovery
Erik De Clercq (Rega Institute for Medical Research, Belgium)
Anti-infective Drug Design and Discovery
Daniel B. Kassel (Analytical & Discovery Technologies, CA, USA)
Combinatorial Chemistry and High Throughput Screening
Chandra Prakash (Pfizer Global Research and Development, CT, USA)
Drug Metabolism
Istvan Toth (University of Queensland, Australia)
Drug Delivery
Ben M. Dunn (University of Florida, FL, USA)
Protein and Peptide Sciences

ADVISORY BOARD MEMBERS
William A. Banks, USA
Günter Blobel, USA (Nobel Laureate)
E. De Clercq, Belgium
Ann K. Daly, UK
William Denny, New Zealand
Ben M. Dunn, USA
Robert J. Gould, USA
Paul Greengard, USA (Nobel Laureate)
Roger Guillemin, USA (Nobel Laureate)
William J. Hoekstra, USA
Kenji Izuhara, Japan
Daniel B. Kassel, USA
William S. Knowles, USA (Nobel Laureate)
Petr Kocis, USA
A. Paul Krapcho, USA
Paul C. Lauterbur, USA (Nobel Laureate)
Jean-Marie Lehn, France (Nobel Laureate)
Kary B. Mullis, USA (Nobel Laureate)
Ferid Murad, USA (Nobel Laureate)
Erwin Neher, Germany (Nobel Laureate)
Chandra Prakash, USA
Allen B. Reitz, USA
Alain Rolland, USA
Andrew V. Schally, USA (Nobel Laureate)
Jens C. Skou, Denmark (Nobel Laureate)
Patrice Talaga, Belgium
E. Donnall Thomas, USA (Nobel Laureate)
Istvan Toth, Australia
Paul Workman, UK
Kurt Wüthrich, Switzerland (Nobel Laureate)
Ahmed Zewail, USA (Nobel Laureate)

PRELIMINARY LIST OF TOPICS
1- Anti-cancer Drug Design and Discovery
2- CNS Drug Design and Discovery
3- Enabling Technology Drug Design and Discovery)
4- Cardiovascular Drug Design and Discovery
5- Frontiers in Medicinal Chemistry
6- Inflammation and Allergy Drug Design and Discovery
7- Anti-infective Drug Design and Discovery
8- Combinatorial Chemistry and High Throughput Screening
9- Drug Metabolism
10- Drug Delivery
11- Protein and Peptide Sciences

Venue

2nd Zaabeel Road,
Dubai
MORE INFO ON THIS VENUE

Types